← Eichor
Study identifier: NCT06678022 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples

Condition: HIV · Viral Load  ·  Sponsor: Makerere University

PhaseNA
Planned participants1086
Who can joinAll sexes, 15 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if the intervention of delivery of antiretroviral drugs by medical drones can improve virological suppression in a fisherfolk community population living with HIV in the islands of Kalangala District, Uganda. The main question it aims to answer is: Can delivery of anti-retroviral therapy (ART) by unmanned aerial vehicles (medical drones) to people living with HIV (PLHIV) improve virological outcomes compared to the standard of care (SOC) in an underserved population? Primary hypothesis: The investigators hypothesize that using drones will increase viral suppression in those receiving the intervention as compared to the control or outcome measure one-will be the proportion of PLHIV with undetectable HIV viral load in the intervention (drones) versus SOC arm at 12 months. If there is a comparison group: Researchers will compare \[Medical Drones delivery group\] to see total cost of 12 months medication delivery to people living with HIV (PLHIV) in the intervention as compared to standard of care (SOC) arm. Proportion PLHIV with an undetectable viral load at 6, 18 and 24 months in intervention Rates of retention in care of PLHIV at 6,12, 18 and 24 months in intervention as compared to SOC arm * Participants will be seen every 6 months for 24 months * They will have blood draws for viral load tests * They will complete interviewer administered questionnaires * The intervention is last-mile delivery of ART by drones to landing sites

This description comes directly from the study's public registry record.

Talk to the study team

Rosalind Principal Investigator, MBBS, MA Hons, MRCP, Ph.D  ·  +256312211422  ·  rratanshi@idi.co.ug

Agnes Bwanika Naggirinya, MBChB, MSC, MMed  ·  +256 312211422  ·  anaggirinya@idi.co.ug

Always discuss trial participation with your own doctor first.

Locations (2)

Bwendero Health CentreKalangala, Ssese, UgandaRecruiting
Mugoye health Centre IIIKalangala, Ssese, UgandaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06678022